We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Zeynep Eroglu

Zeynep Eroglu MD

Department of Cutaneous Oncology, Moffitt Cancer Center; Assistant Professor, Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, Florida

Recent Contributions to PracticeUpdate:

  1. Improved 5-Year Outcomes With Nivolumab Plus Ipilimumab in Advanced Melanoma
  2. Targeted Therapy Responses in Advanced Melanoma With Rare BRAF Mutations
  3. No Survival Benefit for Complete Lymph Node Dissection in Sentinel Node-Positive Melanoma
  4. Dabrafenib, Trametinib, and Pembrolizumab Prolong PFS in BRAF-Mutant Melanoma

Most Read This Week

Recently Updated